Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07073261 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Multiethnic Validation of the Behçet's Syndrome Overall Damage Index (BODI)

Study acronym: PROBE
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
PROBE is an observational multicenter cohort study, consisting of a cross-sectional and a 5-years prospective phase, designed to target the major study objectives, such as testing the comprehensiveness of the Behçet's syndrome Overall Damage Index (BODI) in a wide and ethnically heterogeneous cohort of Behçet's syndrome patients, and investigating how damage assessed by the BODI correlates with other major long-term disease outcomes (5-years mortality and hospitalization rates).
Trial Details
NCT Number NCT07073261
Lead Sponsor University of Cagliari
Collaborators: Hôpital de Hautepierre, University of Siena, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain., Università degli Studi di Ferrara, Tabriz University of Medical Sciences, University of Bari, Cairo University, Tehran University of Medical Sciences, Ibn Sina University Hospital, Rabat, Morocco, Istanbul University, Nazarbayev University School of Medicine, Aristotle University Of Thessaloniki, Mayo Clinic, Centro Hospitalar do Porto, Centro Hospitalar do Tâmega e Sousa, Federal University of São Paulo
Conditions
(from sponsor)		 Behçet's Syndrome (BS)
Related terms Behcet Syndrome
Enrollment 970 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov